Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Tofacitinib is effective and safe for treating alopecia areata.